Movatterモバイル変換


[0]ホーム

URL:


SG11202104838SA - Improved delivery of large agents - Google Patents

Improved delivery of large agents

Info

Publication number
SG11202104838SA
SG11202104838SASG11202104838SASG11202104838SASG11202104838SASG 11202104838S ASG11202104838S ASG 11202104838SASG 11202104838S ASG11202104838S ASG 11202104838SASG 11202104838S ASG11202104838S ASG 11202104838SASG 11202104838S ASG11202104838S ASG 11202104838SA
Authority
SG
Singapore
Prior art keywords
improved delivery
large agents
agents
delivery
improved
Prior art date
Application number
SG11202104838SA
Inventor
Jonathan Edelson
Original Assignee
Eirion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eirion Therapeutics IncfiledCriticalEirion Therapeutics Inc
Publication of SG11202104838SApublicationCriticalpatent/SG11202104838SA/en

Links

Classifications

Landscapes

SG11202104838SA2018-12-032019-11-26Improved delivery of large agentsSG11202104838SA (en)

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
US201862774677P2018-12-032018-12-03
US201962789407P2019-01-072019-01-07
US201962808274P2019-02-202019-02-20
PCT/US2019/063351WO2020117564A1 (en)2018-12-032019-11-26Improved delivery of large agents

Publications (1)

Publication NumberPublication Date
SG11202104838SAtrue SG11202104838SA (en)2021-06-29

Family

ID=68966029

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11202104838SASG11202104838SA (en)2018-12-032019-11-26Improved delivery of large agents

Country Status (12)

CountryLink
US (1)US20220031595A1 (en)
EP (1)EP3890704A1 (en)
JP (2)JP2022510007A (en)
KR (1)KR20210102301A (en)
CN (2)CN113423381A (en)
AU (1)AU2019391791A1 (en)
BR (2)BR112021009554A2 (en)
CA (1)CA3119043A1 (en)
IL (1)IL283627A (en)
MX (2)MX2021006102A (en)
SG (1)SG11202104838SA (en)
WO (1)WO2020117564A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
BR112019010131A2 (en)2016-11-212019-10-08Eirion Therapeutics Inc transdermal delivery of large agents
US12280096B2 (en)2021-07-122025-04-22Penland FoundationTreatments of cancer using nitrous oxide and botulinum toxin
KR20230024669A (en)*2021-08-122023-02-21주식회사 페로카Micro-needle patch
CN114191376B (en)*2022-01-052024-03-01中国药科大学Microneedle patch for treating Alzheimer's disease and preparation method thereof

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US296006A (en)1884-04-01John hoefleb
US4270537A (en)1979-11-191981-06-02Romaine Richard AAutomatic hypodermic syringe
CA1283827C (en)1986-12-181991-05-07Giorgio CirelliAppliance for injection of liquid formulations
GB8704027D0 (en)1987-02-201987-03-25Owen Mumford LtdSyringe needle combination
FR2638359A1 (en)1988-11-031990-05-04Tino Dalto SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN
US5008110A (en)1988-11-101991-04-16The Procter & Gamble CompanyStorage-stable transdermal patch
US5190521A (en)1990-08-221993-03-02Tecnol Medical Products, Inc.Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en)1990-12-131996-06-18Elan Medical Technologies LimitedIntradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (en)1991-09-131991-09-13Kabi Pharmacia Ab INJECTION NEEDLE ARRANGEMENT
US7384918B2 (en)1991-09-242008-06-10Allergan, Inc.Botulinum toxin for treating muscle contracture
US6939852B2 (en)1991-09-242005-09-06Allergan, Inc.Methods and compositions for the treatment of cerebral palsy
US5328483A (en)1992-02-271994-07-12Jacoby Richard MIntradermal injection device with medication and needle guard
US6010715A (en)1992-04-012000-01-04Bertek, Inc.Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en)1993-01-251997-01-07Pharmetrix CorporationLiquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (en)1993-09-021996-06-03Avantgarde Spa MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR VERY LOW DOSAGE DRUGS, IN PARTICULAR HOMEOPATHIC DRUGS.
US5512547A (en)1994-10-131996-04-30Wisconsin Alumni Research FoundationPharmaceutical composition of botulinum neurotoxin and method of preparation
US5641870A (en)1995-04-201997-06-24Genentech, Inc.Low pH hydrophobic interaction chromatography for antibody purification
US5948433A (en)1997-08-211999-09-07Bertek, Inc.Transdermal patch
IT1298087B1 (en)1998-01-081999-12-20Fiderm S R L DEVICE FOR CHECKING THE PENETRATION DEPTH OF A NEEDLE, IN PARTICULAR APPLICABLE TO A SYRINGE FOR INJECTIONS
US5965154A (en)1998-03-171999-10-12Plc Holding, L.L.C.Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en)1998-06-102003-01-07Georgia Tech Research CorporationMicroneedle device for transport of molecules across tissue
US6611707B1 (en)1999-06-042003-08-26Georgia Tech Research CorporationMicroneedle drug delivery device
US6306423B1 (en)2000-06-022001-10-23Allergan Sales, Inc.Neurotoxin implant
US6908453B2 (en)2002-01-152005-06-213M Innovative Properties CompanyMicroneedle devices and methods of manufacture
US20040009180A1 (en)2002-07-112004-01-15Allergan, Inc.Transdermal botulinum toxin compositions
RU2007136617A (en)2005-03-032009-04-10Риванс Терапьютикс, Инк. (Us) COMPOSITION AND METHOD FOR LOCAL USE AND TRANSMISSION OF OLIGOPEPTIDE
JP2009527275A (en)*2006-02-172009-07-30ゾゲニクス インコーポレーティッド Methods and systems for delivery of neurotoxins
WO2008039245A2 (en)2006-04-272008-04-03Anterios, Inc.Assessment of the effects of topical administration of chemodenervating pharmaceuticals
US20120150023A1 (en)2007-08-062012-06-14Kaspar Roger LMicroneedle arrays for active agent delivery
CN102076333A (en)*2008-06-262011-05-25安特里奥公司Dermal delivery
WO2010056922A2 (en)*2008-11-122010-05-20Kythera Biopharmaceuticals, Inc.Systems and methods for delivery of biologically active agents
RU2494769C2 (en)*2008-11-182013-10-103М Инновейтив Пропертиз КомпаниPackage of hollow microneedles and method of using it
EP3332805B1 (en)2008-12-312022-02-23ReVance Therapeutics, Inc.Injectable botulinum toxin formulations
WO2011151723A2 (en)*2010-06-012011-12-08Novartis AgConcentration of vaccine antigens without lyophilization
SG193972A1 (en)2011-01-242013-11-29Anterios IncNanoparticle compositions, formulations thereof, and uses therefor
US20120328702A1 (en)2011-01-242012-12-27Anterios, Inc.Nanoparticle compositions
WO2013096026A1 (en)2011-12-212013-06-273M Innovative Properties CompanyTransdermal adhesive patch assembly with removable microneedle array and method of using same
EP3068423A1 (en)*2013-11-122016-09-21Finzi, EricTreatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
US20170209553A1 (en)*2016-01-222017-07-27Transderm, Inc.Delivery of botulinum with microneedle arrays
KR20190123256A (en)*2016-07-292019-10-31로저 엘. 카스파 How to treat liquid itch
BR112019010131A2 (en)*2016-11-212019-10-08Eirion Therapeutics Inc transdermal delivery of large agents
CN107320841A (en)*2017-08-032017-11-07党明A kind of macromolecule micropin and its preparation method and application

Also Published As

Publication numberPublication date
CA3119043A1 (en)2020-06-11
EP3890704A1 (en)2021-10-13
WO2020117564A1 (en)2020-06-11
US20220031595A1 (en)2022-02-03
MX2021006102A (en)2021-09-21
CN113423381A (en)2021-09-21
KR20210102301A (en)2021-08-19
IL283627A (en)2021-07-29
MX2025005302A (en)2025-06-02
BR112021009554A2 (en)2021-08-17
CN119700637A (en)2025-03-28
AU2019391791A1 (en)2021-06-03
JP2022510007A (en)2022-01-25
BR122023023068A2 (en)2024-02-20
JP2024170568A (en)2024-12-10

Similar Documents

PublicationPublication DateTitle
GB201820166D0 (en)Therapeutic agents
GB201820165D0 (en)Therapeutic agents
GB201709456D0 (en)Therapeutic agents
GB201814169D0 (en)Blockchain autonoumous agents
ZA201903467B (en)Transdermal delivery of large agents
IL283627A (en)Improved delivery of large agents
GB201603104D0 (en)Therapeutic agents
GB201805816D0 (en)Therapeutic agents
IL282585A (en)Aerosolised formulation
IL282546A (en)Aerosolised formulation
ZA202103582B (en)Dna-cutting agent
ZA202103578B (en)Dna-cutting agent
GB201700553D0 (en)Therapeutic agents
GB201511126D0 (en)Spray device for the delivery of therapeutic agents
IL251588A0 (en)Methods and compositions for increasing the potency of antifungal agents
IL277358A (en)Omniphilic nano-vesicles based on modified polysaccharides for delivery of active agents
GB201600376D0 (en)Novel therapeutic agents
SG11202105136WA (en)Application of chidamide
HK40062193A (en)Improved delivery of large agents
GB201620948D0 (en)Therapeutic agents
GB201616563D0 (en)Therapeutic agents
GB201820168D0 (en)Therapeutic agents
GB201820172D0 (en)Therapeutic agents
GB201820160D0 (en)Therapeutic agents
GB201820162D0 (en)Therapeutic agents

[8]ページ先頭

©2009-2025 Movatter.jp